94790-24-6

Basic information

• Product Name: oc-O-Methyl-L-TyrosineMethylEster
• Synonyms: oc-O-Methyl-L-TyrosineMethylEster;METHYL (2R)-2-[(TERT-BUTOXY)CARBONYLAMINO]-3-(4-METHOXYPHENYL)PROPANOATE;Methyl N-Boc-O-methyl-L-tyrosinate;(S)-2-[(tert-Butoxycarbonyl)amino]-3-(4-methoxyphenyl)propionic acid methyl ester;N-tert-Butoxycarbonyl-O-methyl-L-tyrosine methyl ester;O-methyl-N-tert-butoxycarbonyl-L-tyrosine methyl ester;Boc-4-methoxy-L-phenylalanine methyl ester;Boc-L-Tyr(Me)-OMe
• CAS NO: 94790-24-6
• Molecular Formula: C₁₆H₂₃NO₅
• Molecular Weight: 309.36
• Mol File: 94790-24-6.mol
• Article Data: 47

Chemical Properties

• Appearance: /
• CAS DataBase Reference: oc-O-Methyl-L-TyrosineMethylEster(CAS DataBase Reference)
• NIST Chemistry Reference: oc-O-Methyl-L-TyrosineMethylEster(94790-24-6)
• EPA Substance Registry System: oc-O-Methyl-L-TyrosineMethylEster(94790-24-6)

Safety Data

• Hazardous Substances Data: 94790-24-6(Hazardous Substances Data)

Usage

General Description

oc-O-Methyl-L-TyrosineMethylEster is a chemical compound that is derived from the amino acid tyrosine. It is an ester derivative of 3-O-methyl-L-tyrosine and is primarily used in the field of organic chemistry and biochemistry for research purposes. It has been found to exhibit potential pharmacological properties and may be of interest in drug development. Additionally, this compound has also been studied for its potential role in the treatment of certain neurological and psychiatric disorders. However, further research is needed to fully understand its biological activities and potential applications in medicine.

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 17355-19-0 methyl (R)-2-amino-3-(4-methoxyphenyl)propanoate 
• 76757-90-9 N-(tert-butoxycarbonyl)-D-tyrosine methyl ester 
• 77-78-1 dimethyl sulfate 
• 74-88-4 methyl iodide 
• 3978-80-1 Boc-Tyr-OH 
• 7479-01-8 O-methyl-L-tyrosine methyl ester hydrochloride 
• 4326-36-7 (S)-N-(tert-butoxycarbonyl)tyrosine methyl ester 
• 696-62-8 para-iodoanisole 
• 93267-04-0 N-(tert-butoxycarbonyl)-L-3-iodoalanine methyl ester 
• 2766-43-0 N-tert-butyloxycarbonyl-L-serine methyl ester 
• 104-92-7 1-bromo-4-methoxy-benzene 
• 556-02-5 tyrosine 
• 70642-86-3 N-(tert-butoxycarbonyl)-D-tyrosine 

Downstream Products

• 113850-71-8 (S )-methyl 2-((tert-butoxycarbonyl)amino)-3-(3-iodo-4-methoxyphenyl)propanoate 
• 150831-56-4 C₁₆H₂₂ClNO₄ 
• 1240017-65-5 (5S,6R,7R,10aR)-6-hydroxy-5-(4-methoxybenzyl)tetrahydro-1H-7,10a-methanopyrrolo[1,2-a]azocine-3,8(2H,5H)-dione 
• 1240017-59-7 (5S,6R,7S,10aR)-6,8-dihydroxy-5-(4-methoxybenzyl)octahydro-3H-7,10a-methanopyrrolo[1,2-a]-azocin-3-one 
• 1240017-60-0 (5S,6R,7R,10aR)-8-{[tert-butyl(dimethyl)silyl]oxy}-6-hydroxy-5-(4-methoxybenzyl)octahydro-3H-7,10a-methanopyrrolo[1,2-a]azocin-3-one 
• 1240017-54-2 (5S,7S,10aR)-8-{[tert-butyl(dimethyl)silyl]oxy}-5-(4-methoxybenzyl)tetrahydro-1H-7,10a-methanopyrrolo[1,2-a]azocine-3,6(2H,5H)-dione 
• 1449125-47-6 (5S,6S,7R,10aR)-8-{[tert-butyl(dimethyl)silyl]oxy}-6-hydroxy-5-(4-methoxybenzyl)octahydro-3H-7,10a-methanopyrrolo[1,2-a]azocin-3-one 
• 1449125-48-7 (5S,6S,7S,10aR)-6,8-bis{[tert-butyl(dimethyl)silyl]oxy}-5-(4-methoxybenzyl)octahydro-3H-7,10amethanopyrrolo[1,2-a]azocin-3-one 
• 248948-75-6 (2S,5S,6S,7R,8S,10aS)-2-[[(benzyloxy)carbonyl]methylamino]octahydro-6-hydroxy-5-[(4-methoxyphenyl)methyl]-1H-7,10a-methanopyrrolo[1,2-a]azocin-8-yl dibenzyl phosphate 
• 70601-64-8 (R)-4-methoxyphenylalanine methyl ester hydrochloride 
• 1610691-82-1 (R)-N-(2-chloroacetyl)-4-methoxyphenylalanine methyl ester 
• 1610691-86-5 (R)-N-[N-(2,2-dimethoxyethyl)glycinyl]-4-methoxyphenylalanine methyl ester 
• 1620204-74-1 (S)-methyl 2-(tert-butoxycarbonylamino)-3-(3-(phthalimidyl)-4-methoxyphenyl)propanoate 
• 1620204-75-2 (S)-methyl 2-(tert-butoxycarbonylamino)-3-(2-(phthalimidyl)-4-methoxyphenyl)propanoate 

Relevant articles and documents

Synthesis of Enantiopure Unnatural Amino Acids by Metallaphotoredox Catalysis

We describe herein a two-step process for the conversion of serine to a wide array of optically pure unnatural amino acids. This method utilizes a photocatalytic cross-electrophile coupling between a bromoalkyl intermediate and a diverse set of aryl halides to produce artificial analogues of phenylalanine, tryptophan, and histidine. The reaction is tolerant of a broad range of functionalities and can be leveraged toward the scalable synthesis of valuable pharmaceutical scaffolds via flow technology.

BORYLATED AMINO ACID COMPOSITIONS FOR USE IN BORON NEUTRON CAPTURE THERAPY AND METHODS THEREOF

Borylated Amino Acid ("BAA") compositions and methods of making BAAs are disclosed herein. Consequently, the BAAs can be administered to patients as a Neutron Capture Agent and provide a method of treating cancer, immunological disorders and other disease by utilizing a Neutron Capture Therapy modality.

Rapid Syntheses of (?)-FR901483 and (+)-TAN1251C Enabled by Complexity-Generating Photocatalytic Olefin Hydroaminoalkylation

We report a common strategy to facilitate the syntheses of the polycyclic alkaloids (?)-FR901483 (1) and (+)-TAN1251C (2). A divergent synthetic strategy provides access to both natural products through a pivotal spirolactam intermediate (3), which can be accessed on a gram-scale. A photocatalytic olefin hydroaminoalkylation brings together three readily available building blocks and forges the majority of the carbon framework present in 1 and 2 in a single operation, leading to concise total syntheses. The complexity-generating photocatalytic process also provides direct access to novel non-racemic spirolactam scaffolds that are likely to be of interest to early-stage drug discovery programs.